Related references
Note: Only part of the references are listed.The Pathobiology of Pulmonary Arterial Hypertension
Sudarshan Rajagopal et al.
CARDIOLOGY CLINICS (2022)
Phenotypic Diversity of Vascular Smooth Muscle Cells in Pulmonary Arterial Hypertension Implications for Therapy
Benoit Lechartier et al.
CHEST (2022)
Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective
Ran-ran Wang et al.
PHARMACOLOGICAL RESEARCH (2022)
Kinases as potential targets for treatment of pulmonary hypertension and right ventricular dysfunction
Astrid Weiss et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Involvement of mitogen-activated protein kinase (MAPK)-activated protein kinase 2 (MK2) in endothelial dysfunction associated with pulmonary hypertension
Mohammad Shafiq et al.
LIFE SCIENCES (2021)
Diversity and versatility of p38 kinase signalling in health and disease
Begona Canovas et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)
Atypical p38 Signaling, Activation, and Implications for Disease
Jeremy C. Burton et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Stress Relief Techniques: p38 MAPK Determines the Balance of Cell Cycle and Apoptosis Pathways
Robert H. Whitaker et al.
BIOMOLECULES (2021)
Sotatercept for the Treatment of Pulmonary Arterial Hypertension
Marc Humbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Molecules linked to Ras signaling as therapeutic targets in cardiac pathologies
Manuel Ramos-Kuri et al.
BIOLOGICAL RESEARCH (2021)
Perioperative Management of Pulmonary Hypertension. A Review
Christopher Wood et al.
JOURNAL OF CRITICAL CARE MEDICINE (2021)
Neutralization of CXCL12 attenuates established pulmonary hypertension in rats
Jennifer Bordenave et al.
CARDIOVASCULAR RESEARCH (2020)
Chronic inflammation within the vascular wall in pulmonary arterial hypertension: more than a spectator
Alice Huertas et al.
CARDIOVASCULAR RESEARCH (2020)
New Benzofuran N-Acylhydrazone Reduces Cardiovascular Dysfunction in Obese Rats by Blocking TNF-Alpha Synthesis
Gizele Cabral Costa et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Therapeutic Benefit of the Association of Lodenafil with Mesenchymal Stem Cells on Hypoxia-induced Pulmonary Hypertension in Rats
Marina de Moraes Carvalho da Silva et al.
CELLS (2020)
Resveratrol downregulates TNF-α-induced monocyte chemoattractant protein-1 in primary rat pulmonary artery endothelial cells by P38 mitogen-activated protein kinase signaling
Jian-Wei Lin et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
An overview of the 6th World Symposium on Pulmonary Hypertension
Nazzareno Galie et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
Marc Humbert et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Periostin Mediates Right Ventricular Failure through Induction of Inducible Nitric Oxide Synthase Expression in Right Ventricular Fibroblasts from Monocrotaline-Induced Pulmonary Arterial Hypertensive Rats
Keisuke Imoto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases
Alice Huertas et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of Echocardiography
Daniel X. Augustine et al.
ECHO RESEARCH AND PRACTICE (2018)
Discovery of naphthyl-N-acylhydrazone p38 MAPK inhibitors with in vivo anti-inflammatory and anti-TNF- activity
Rosana H. C. N. Freitas et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2018)
Activation of GPER ameliorates experimental pulmonary hypertension in male rats
Allan K. Alencar et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling
Liam A. Hurst et al.
NATURE COMMUNICATIONS (2017)
Activation of LXRα improves cardiac remodeling induced by pulmonary artery hypertension in rats
Yibo Gong et al.
SCIENTIFIC REPORTS (2017)
p38 MAPK Inhibition Improves Heart Function in Pressure-Loaded Right Ventricular Hypertrophy
Baktybek Kojonazarov et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2017)
Modulation of Intersectin-1s Lung Expression Induces Obliterative Remodeling and Severe Plexiform Arteriopathy in the Murine Pulmonary Vascular Bed
Monal Patel et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Pulmonary Hypertension
Marius M. Hoeper et al.
DEUTSCHES ARZTEBLATT INTERNATIONAL (2017)
Baicalin Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension to Improve Hypoxic Cor Pulmonale by Reducing the Activity of the p38 MAPK Signaling Pathway and MMP-9
Shuangquan Yan et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
A global view of pulmonary hypertension
Marius M. Hoeper et al.
LANCET RESPIRATORY MEDICINE (2016)
The reversal of pulmonary vascular remodeling through inhibition of p38 MAPK-alpha: a potential novel anti-inflammatory strategy in pulmonary hypertension
Alistair C. Church et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
Compromised MAPK signaling in human diseases: an update
Eun Kyung Kim et al.
ARCHIVES OF TOXICOLOGY (2015)
Temporal hemodynamic and histological progression in Sugen5416/hypoxia/normoxia-exposed pulmonary arterial hypertensive rats
Michie Toba et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
Mammalian Target of Rapamycin Complex 2 ( mTORC2) Coordinates Pulmonary Artery Smooth Muscle Cell Metabolism, Proliferation, and Survival in Pulmonary Arterial Hypertension
Dmitry A. Goncharov et al.
CIRCULATION (2014)
N-acylhydrazone derivative ameliorates monocrotaline-induced pulmonary hypertension through the modulation of adenosine AA2R activity
Allan K. N. Alencar et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
IGF-1 induces iNOS expression via the p38 MAPK signal pathway in the anti-apoptotic process in pulmonary artery smooth muscle cells during PAH
Chengtao Jin et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2014)
Beneficial effects of a novel agonist of the adenosine A2A receptor on monocrotaline-induced pulmonary hypertension in rats
Allan K. N. Alencar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
The Effect of c-fos on Acute Myocardial Infarction and the Significance of Metoprolol Intervention in a Rat Model
Song Zhang et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2013)
Effects of Purple Grape Juice in the Redox-sensitive Modulation of Right Ventricular Remodeling in a Pulmonary Arterial Hypertension Model
Francisca Mosele et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension
Revathi Rajkumar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension
Dalia Urboniene et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2010)
Mechanisms and functions of p38 MAPK signalling
Ana Cuadrado et al.
BIOCHEMICAL JOURNAL (2010)
TNF-α inhibition attenuates adverse myocardial remodeling in a rat model of volume overload
Lynetta J. Jobe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure
Kurt R. Stenmark et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
The signal transduction pathway of PKC/NF-κB/c-fos may be involved in the influence of high glucose on the cardiomyocytes of neonatal rats
Wang Min et al.
CARDIOVASCULAR DIABETOLOGY (2009)
Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension
Liliana Moreno-Vinasco et al.
PHYSIOLOGICAL GENOMICS (2008)
BMP4 induces HO-1 via a Smad-independent, p38MAPK-dependent pathway in pulmonary artery myocytes
Xudong Yang et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy
Dirk Westermann et al.
BASIC RESEARCH IN CARDIOLOGY (2007)
P38 MAP kinase: Essential role in hypoxia-mediated human pulmonary artery fibroblast proliferation
Heather J. Mortimer et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2007)
Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension
T Itoh et al.
RESPIROLOGY (2006)
Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats\
J Lu et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2004)
p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat
F See et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension
TM Bull et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells
S Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)
Stress-activated cytokines and the heart: From adaptation to maladaptation
DL Mann
ANNUAL REVIEW OF PHYSIOLOGY (2003)
Serial noninvasive assessment of progressive pulmonary hypertension in a rat model
JE Jones et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Roles of tumor necrosis factor p55 and p75 receptors in TNF-α-induced vascular permeability
E Ferrero et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2001)
TNF alpha is required for hypoxia-mediated right ventricular hypertrophy
RM Smith et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2001)
Share Paper
